Testing the Translational Potential of Rapamycin on Healthy Aging

Abstract

Treatment with rapamycin, an inhibitor of the mechanistic Target Of Rapamycin Complex One (mTORC1) protein kinase, has been repeatedly demonstrated to extend lifespan and prevent or delay several age-related diseases in diverse model systems.